Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Specks

Showing results (1-10 of 65) with videos related to

Pageof 7
Sort By:
Arthritis Research|November 30, 2000
What you should know about PR3-ANCA. Conformational requirements of proteinase 3 (PR3) for enzymatic activity and recognition by PR3-ANCAU Specks
Current Opinion in Rheumatology|January 10, 2001
Diffuse alveolar hemorrhage syndromesU Specks
Clinical and Experimental Rheumatology|January 29, 2005
Antineutrophil cytoplasmic antibodies: are they pathogenic?U Specks
Current Opinion in Rheumatology|January 27, 2000
Are animal models of vasculitis suitable tools?U Specks
Rheumatic Diseases Clinics of North America|November 29, 2001
Are antineutrophil cytoplasmic antibodies pathogenic? Experimental approaches to understand the antineutrophil cytoplasmic antibody phenomenonK A Russell, U Specks
Bulletin on the Rheumatic Diseases|November 7, 1998
Antineutrophil cytoplasmic antibodiesG S Hoffman, U Specks
Monographs in Pathology|January 1, 1993
Wegener's granulomatosis in the 1990s--a pulmonary pathologist's perspectiveT V Colby, U Specks
Pneumologie (Stuttgart, Germany)|February 1, 1990
Do anticytoplasmic autoantibodies (ACPA) extend our understanding of the spectrum of Wegener's granulomatosis?U Specks, R A DeRemee
Mayo Clinic Proceedings|December 1, 1994
Anti-neutrophil cytoplasmic antibodiesU Specks, H A Homburger
Rheumatic Diseases Clinics of North America|May 1, 1990
Granulomatous vasculitis. Wegener's granulomatosis and Churg-Strauss syndromeU Specks, R A DeRemee
Pageof 7

Showing results (1-10 of 65) with videos related to

Sort By:
Pageof 7
Arthritis Research|November 30, 2000
What you should know about PR3-ANCA. Conformational requirements of proteinase 3 (PR3) for enzymatic activity and recognition by PR3-ANCAU Specks
Current Opinion in Rheumatology|January 10, 2001
Diffuse alveolar hemorrhage syndromesU Specks
Clinical and Experimental Rheumatology|January 29, 2005
Antineutrophil cytoplasmic antibodies: are they pathogenic?U Specks
Current Opinion in Rheumatology|January 27, 2000
Are animal models of vasculitis suitable tools?U Specks
Rheumatic Diseases Clinics of North America|November 29, 2001
Are antineutrophil cytoplasmic antibodies pathogenic? Experimental approaches to understand the antineutrophil cytoplasmic antibody phenomenonK A Russell, U Specks
Bulletin on the Rheumatic Diseases|November 7, 1998
Antineutrophil cytoplasmic antibodiesG S Hoffman, U Specks
Monographs in Pathology|January 1, 1993
Wegener's granulomatosis in the 1990s--a pulmonary pathologist's perspectiveT V Colby, U Specks
Pneumologie (Stuttgart, Germany)|February 1, 1990
Do anticytoplasmic autoantibodies (ACPA) extend our understanding of the spectrum of Wegener's granulomatosis?U Specks, R A DeRemee
Mayo Clinic Proceedings|December 1, 1994
Anti-neutrophil cytoplasmic antibodiesU Specks, H A Homburger
Rheumatic Diseases Clinics of North America|May 1, 1990
Granulomatous vasculitis. Wegener's granulomatosis and Churg-Strauss syndromeU Specks, R A DeRemee
Pageof 7